Oscar Health, Inc.
OSCR · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,985,984 | $2,863,945 | $3,046,263 | $2,392,813 |
| % Growth | 4.3% | -6% | 27.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2,985,984 | $2,863,945 | $3,046,263 | $2,392,813 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $534,485 | $482,759 | $466,580 |
| SG&A Expenses | $521,592 | $534,485 | $482,759 | $466,580 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,593,642 | $2,551,031 | $2,275,293 | $2,079,922 |
| Operating Expenses | $3,115,234 | $3,085,516 | $2,758,052 | $2,546,502 |
| Operating Income | -$129,250 | -$233,536 | $288,211 | -$153,689 |
| % Margin | -4.3% | -8.2% | 9.5% | -6.4% |
| Other Income/Exp. Net | -$10,041 | $0 | $0 | $0 |
| Pre-Tax Income | -$139,291 | -$233,536 | $288,211 | -$153,689 |
| Tax Expense | -$1,807 | -$5,045 | $12,705 | -$404 |
| Net Income | -$137,450 | -$228,361 | $275,271 | -$153,547 |
| % Margin | -4.6% | -8% | 9% | -6.4% |
| EPS | -0.53 | -0.89 | 1.1 | -0.62 |
| % Growth | 40.4% | -180.9% | 277.4% | – |
| EPS Diluted | -0.53 | -0.89 | 0.92 | -0.62 |
| Weighted Avg Shares Out | 259,273 | 253,417 | 251,279 | 240,386 |
| Weighted Avg Shares Out Dil | 259,273 | 270,244 | 305,938 | 265,853 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6,857 | $5,847 | $5,994 | $6,026 |
| Depreciation & Amortization | $7,312 | $6,970 | $6,730 | $9,233 |
| EBITDA | -$125,122 | -$220,719 | $300,935 | -$138,430 |
| % Margin | -4.2% | -7.7% | 9.9% | -5.8% |